| Axitinib versus sorafenib as second-line therapy in Asian patients with metastatic renal cell carcinoma (mRCC): Results from a registrational study. | |
| Qin, Shukui; Bi, Feng; Cheng, Ying; Guo, Jun; Ren, Xiu Bao; Huang, Yiran; Wang, Jinwan; Ben, Yong; Kim, Sinil; Tang, Jie | |
| 2012 | |
| 卷号 | 30 |
| 期号 | 15 |
| 会议录 | JOURNAL OF CLINICAL ONCOLOGY
 |
| 语种 | 英语 |
| URL标识 | 查看原文 |
| ISSN号 | 0732-183X |
| 内容类型 | 会议论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4910692 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Qin, Shukui,Bi, Feng,Cheng, Ying,et al. Axitinib versus sorafenib as second-line therapy in Asian patients with metastatic renal cell carcinoma (mRCC): Results from a registrational study.[C]. 见:. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论